Efficacy of Azithromycin in Treatment of Bronchiectasis
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Bronchiectasis is a chronic lung condition characterised primarily by dilatation of the
airways. Only a small number of clinical studies have been conducted investigating the use of
macrolides to treat non-cystic fibrosis bronchiectasis. The purpose of this study is to
determine the efficacy of 12 weeks treatment with azithromycin in adult patients with
non-cystic fibrosis bronchiectasis.